Lacove 50mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing. This mechanism contributes to its efficacy in reducing seizure frequency. Lacove is typically administered orally, with dosage individualized based on clinical response and tolerability. It may be used as monotherapy or adjunctive therapy in adults and pediatric patients aged four years and above. Common adverse effects include dizziness, headache, nausea, and diplopia, which are generally mild to moderate in severity. Caution is advised in patients with cardiac conduction abnormalities, as lacosamide can prolong PR interval. Regular monitoring of cardiac function is recommended in at-risk populations. Lacove should be used with care in patients with hepatic or renal impairment, with dose adjustments as necessary. It is contraindicated in individuals with known hypersensitivity to lacosamide or any excipients. Concomitant use with other sodium channel blockers may increase the risk of adverse effects. Patients should be counseled regarding potential side effects and advised not to discontinue therapy abruptly to avoid seizure exacerbation.